Biofrontera annual depreciation and amortization
2020
2021
2022
2023
2024
2025
Biofrontera Depreciation & Amortization Growth & History (BFRI)
Biofrontera's depreciation and amortization was $138,000 for fiscal 2025.
View full Biofrontera company overviewBiofrontera annual depreciation and amortization history
| Fiscal year | Period ended | Depreciation and amortization | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $138,000 | −$283,000 | −67.22% |
| 2024 | 2024-12-31 | $421,000 | −$179,000 | −29.83% |
| 2023 | 2023-12-31 | $600,000 | $81,000 | +15.61% |
| 2022 | 2022-12-31 | $519,000 | −$21,000 | −3.89% |
| 2021 | 2021-12-31 | $540,000 | −$22,000 | −3.91% |
| 2020 | 2020-12-31 | $562,000 | — | — |
Biofrontera quarterly depreciation and amortization
Q3.20
Q1.21
Q2.21
Q3.21
Q1.22
Q2.22
Q3.22
Q1.23
Q2.23
Q3.23
Q1.24
Q2.24
Q3.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Depreciation and amortization | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $65,000 | $39,000 | +150.00% |
| Q1 2026 | 2026-03-31 | $55,000 | $26,000 | +89.66% |
| Q4 2025 | 2025-12-31 | $220,000 | — | — |
| Q3 2025 | 2025-09-30 | $68,000 | −$61,000 | −47.29% |
| Q2 2025 | 2025-06-30 | $26,000 | −$95,000 | −78.51% |
| Q1 2025 | 2025-03-31 | $29,000 | −$99,000 | −77.34% |
| Q3 2024 | 2024-09-30 | $129,000 | $8,000 | +6.61% |
| Q2 2024 | 2024-06-30 | $121,000 | −$1,000 | −0.82% |
| Q1 2024 | 2024-03-31 | $128,000 | $1,000 | +0.79% |
| Q3 2023 | 2023-09-30 | $121,000 | −$5,000 | −3.97% |
| Q2 2023 | 2023-06-30 | $122,000 | −$4,000 | −3.17% |
| Q1 2023 | 2023-03-31 | $127,000 | −$4,000 | −3.05% |
| Q3 2022 | 2022-09-30 | $126,000 | −$3,000 | −2.33% |
| Q2 2022 | 2022-06-30 | $126,000 | −$11,000 | −8.03% |
| Q1 2022 | 2022-03-31 | $131,000 | −$7,000 | −5.07% |
| Q3 2021 | 2021-09-30 | $129,000 | $93,000 | +258.33% |
| Q2 2021 | 2021-06-30 | $137,000 | — | — |
| Q1 2021 | 2021-03-31 | $138,000 | — | — |
| Q3 2020 | 2020-09-30 | $36,000 | — | — |
Biofrontera depreciation and amortization trends
Over the last five fiscal years, Biofrontera's depreciation and amortization decreased from $562,000 to $138,000, a change of −$424,000. The latest reported quarter, Q2 2026, shows $65,000.
About the metric
What depreciation and amortization mean
Depreciation and amortization allocate the cost of tangible and intangible assets over their useful lives. These non-cash expenses reduce reported earnings and are commonly added back when calculating EBITDA and operating cash flow.
Calculation and source
Reported depreciation and amortization
TickerStat uses a combined depreciation and amortization value when reported. If a company reports the two components separately for an aligned period, they are added together without duplicating overlapping facts. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Biofrontera source filings ↗